logo
India's top court orders officials to move stray dogs to shelters in Delhi

India's top court orders officials to move stray dogs to shelters in Delhi

BBC News3 days ago
India's top court has ordered authorities in Delhi and its suburbs to move all stray dogs from streets to animal shelters.The court expressed concerns over rising "menace of dog bites leading to rabies" and gave an eight-week deadline to officials to finish the task. Delhi's stray dog population is estimated at one million, with suburban Noida, Ghaziabad, and Gurugram also seeing a rise, municipal sources say.India has millions of stray dogs and the country accounts for 36% of the total rabies-related deaths in the world, according to the World Health Organization.
Do India's stray dogs kill more people than terror attacks?"Infants and young children, not at any cost, should fall prey to rabies. The action should inspire confidence that they can move freely without fear of being bitten by stray dogs," legal news website Live Law quoted the court as saying on Monday.The court took up the issue following reports of increasing dog bites in Delhi and other major cities.The court directed that multiple shelters be established across Delhi and its suburbs, each capable of housing at least 5,000 dogs. These shelters should be equipped with sterilisation and vaccination facilities, as well as CCTV cameras.The court ruled sterilised dogs must not be released in public areas, despite current rules requiring their return to the capture site.It also ordered that a helpline should be set up within a week to report dog bites and rabies cases.Animal welfare groups, however, have voiced strong concerns over the court's directive. They said that the timeline set up by the court was unrealistic. "Most Indian cities currently do not have even 1% of the capacity [needed] to rehabilitate stray dogs in shelters," said Nilesh Bhanage, founder of PAWS, a prominent animal rights group."If the court and the authorities actually want to end the menace, they should focus on strengthening the implementation of the existing regulations to control dog population and rabies - they include vaccination, sterilisation and efficient garbage management."Government data shows that there were 3.7 million reported cases of dog bites across the country in 2024.Activists say the true extent of rabies-related deaths is not fully known.The World Health Organization says that "the true burden of rabies in India is not fully known; although as per available information, it causes 18,000-20,000 deaths every year".On the other hand, according to data submitted in the parliament by the Indian government, 54 rabies deaths were recorded in 2024, up from 50 in 2023.Follow BBC News India on Instagram, YouTube, X and Facebook
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NHS Fife 'broke the law' claims EHRC amid Sandie Peggie tribunal
NHS Fife 'broke the law' claims EHRC amid Sandie Peggie tribunal

The National

time3 hours ago

  • The National

NHS Fife 'broke the law' claims EHRC amid Sandie Peggie tribunal

The Herald reports that the Equality and Human Rights Commission (EHRC) has told the health board to carry out an equality impact assessment, after it emerged one had not been carried out ahead of NHS Fife allowing a transgender doctor to use female changing facilities. Peggie, a nurse, was suspended after she complained about having to share a changing room with transgender medic Dr Beth Upton at Victoria Hospital in Kirkcaldy, Fife, on Christmas Eve 2023. She was placed on special leave after Dr Upton made an allegation of bullying and harassment, and cited concerns about 'patient care'. READ MORE: Scottish Enterprise panned for lack of checks on Israeli-linked arms firms Peggie then lodged a claim against NHS Fife and Dr Upton, citing the Equality Act 2010, including sexual harassment; harassment related to a protected belief; indirect discrimination; and victimisation. The tribunal has become a flash point for gender-critical campaigners and anti-trans groups, with For Women Scotland, which took the case regarding the definition of a woman to the Supreme Court, being permitted to lodge a written intervention to the tribunal. Peggie's legal team requested a copy of any relevant impact assessments undertaken by the health board in August 2024. According to the Herald, the health board responded that it had not. This led to the EHRC writing to NHS Fife on multiple occasions. They said that under the Equality Act 2010, the health board had a 'duty to assess and review proposed new or revised policies or practices' and to publish them within a 'reasonable period'. The Supreme Court ruling on the definition of a woman as 'biological sex' was handed down on April 16 2025, after the EHRC first wrote to NHS Fife. The judgment led to the EHRC to release interim guidance – which banned transgender people from using the facilities of their acquired gender. It also made it compulsory for workplaces to provide single-sex facilities, a statement it would later retract. A consultation is currently underway, before the EHRC releases its full guidance. Prior to the Supreme Court ruling, the Equality Act had been seen as including transgender women with a Gender Recognition Certificate (GRC) as women. Baroness Kishwer Falkner, EHRC chair, said: 'Undertaking an equality impact assessment of relevant policies or practices, and publishing the results, are requirements of the PSED Specific Duties in Scotland. We believe NHS Fife failed to meet these requirements and told them to carry one out immediately. (Image: PA) 'NHS Fife has now confirmed that it has commissioned an equality impact assessment and anticipates it will be published by September 30. 'Since we first wrote to NHS Fife, the Supreme Court ruled on the definition of 'sex' in the Equality Act. The EHRC has been clear that all duty-bearers should be following the law, as set out in the judgment handed down on April 16. NHS Fife has assured us that it is following our advice to review the implications of the judgment for its policies and procedures, seeking specialist legal advice where necessary. 'We continue to urge NHS Fife to progress the corrective actions we directed without delay. These steps are essential to protect NHS Fife staff from discrimination and harassment on the basis of protected characteristics, including sex, religion or belief, and gender reassignment. 'We will continue to engage with NHS Fife and monitor its progress and the outcome of the measures it has committed to taking, to ensure compliance with the Equality Act and Public Sector Equality Duty.' In response, a spokesperson for the health board said: 'NHS Fife acknowledges the Equality and Human Rights Commission's media release of 13 August 2025 and welcomes its continued engagement and oversight. READ MORE: Pro-Palestine protesters meet JD Vance as he lands in Scotland 'We are committed to working constructively with the EHRC to provide assurance that we fully understand, and are meeting, our obligations under the Equality Act 2010 and the Public Sector Equality Duty. 'This includes considering the implications of the recent Supreme Court ruling and the EHRC's interim guidance. 'A comprehensive review and audit of our facilities has been completed, and an Equality Impact Assessment is underway. This will be concluded and published by 30 September 2025. 'Our priority is to ensure that all NHS Fife policies and practices protect the rights of our staff and comply fully with equality legislation.'

Virus cases rise among travellers returning to Britain
Virus cases rise among travellers returning to Britain

The Independent

time6 hours ago

  • The Independent

Virus cases rise among travellers returning to Britain

UK health authorities have urged holidaymakers to take precautions against mosquito bites due to a significant rise in chikungunya virus cases among travellers returning to Britain. The UK Health Security Agency (UKHSA) reported 73 cases of chikungunya between January and June 2025, a notable increase from 27 cases in the same period last year, with most linked to travel to Sri Lanka, India, and Mauritius. Chikungunya, spread by mosquito bites, causes sudden fever and joint pain, though serious complications are rare and there is currently no risk of onward transmission within the UK. The UKHSA has also detected the first three cases of the oropouche virus in the UK, all associated with travel from Brazil, which is spread by midge bites and causes flu-like symptoms. Officials advise travellers to use insect repellent, cover skin, and consider insecticide-treated bed nets, while also noting a rise in travel-associated cholera cases and a decrease in dengue and zika cases.

Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry
Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry

Reuters

timea day ago

  • Reuters

Lilly launches Mounjaro pen in India at $160 for starting dose, stepping up Novo rivalry

Aug 13 (Reuters) - Eli Lilly (LLY.N), opens new tab on Wednesday launched the easy-to-use injector pen of its blockbuster weight-loss drug Mounjaro for 14,000 rupees (nearly $160) for its starting dose of 2.5 mg in India, stepping up competition with Novo Nordisk ( opens new tab. Lilly said in June it received approval from India's drug regulator for its once-weekly Mounjaro Kwikpen, two days after Novo Nordisk launched Wegovy in multiple dose strengths in a similar pen device. Mounjaro Kwikpen is available in six dose strengths — 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg and 15 mg — with pricing calculated for a month's supply. The smallest two doses are priced at 14,000 and 17,500 rupees, respectively, and the 7.5 mg and 10 mg doses cost 22,000 rupees. The 12.5 mg and 15 mg doses cost 27,500 rupees, the company said. "If we look at how the highest doses of Mounjaro and Wegovy are priced, it appears (that) Mounjaro's pricing is attractive and competitive," said Vishal Manchanda from Systematix Institutional Equities. Wegovy's smallest doses of 0.25 mg, 0.5 mg and 1 mg cost 17,345 rupees a month, and its highest doses of 1.7 mg and 2.4 mg cost 24,280 rupees and 26,015 rupees a month, respectively. Lilly began selling Mounjaro in India in late March for diabetes and obesity in 2.5 mg and 5 mg vials. Both drugs have seen strong demand since then, with sales in July doubling month-on-month. The drugs belong to a class of therapies known as GLP-1 receptor agonists that help control blood sugar and slow digestion, making people feel fuller for longer. ($1 = 87.6650 Indian rupees)

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store